Академический Документы
Профессиональный Документы
Культура Документы
S.M. MUDDA
1
REGULATORY REQUIREMENTS US FDA under its Pharmaceutical CGMPs for the 21st Century initiative saw the need to harmonize CGMPS with the globally followed Quality Systems. As a result of this initiative, FDA has issued a guidance for the industry Quality Systems Approach to Pharmaceutical CGMP Regulations
8
PREPARATION FOR THE AUDITS The first requirement is to have a Management Team working under a welldefined organization chart The individual identified to lead the inspection is usually the Head of QA and the other key members are: Head of Production Head of Quality Control
10
PREPARATION FOR THE AUDITS Documentation for Quality System Level 1:Quality Manual Level 2:Quality Assurance Procedures Level 3:Work Instructions (SOPs) Level4: Forms and Records
13
Master Documents
Operating Procedures
Stores Procedures
Production Procedures
Maintenance Procedures
14
Product Design and Technology Transfer Creation and Approval of Artworks Stability Studies of Drug Products
Design & Control of Documents Design of Master Documents Design of Validation Documents Preparation of Site Master File
QAP : 034 Handling of Materials for Product Development QAP : 035 QAP : 036 QAP : 037 Process Validation Cleaning Validation Validation of Analytical Method
Management Organization
Item Codification System Vendor Approval Indent and Purchase of Raw and Packing Material Receipt, Storage & Handling of Raw & Packing Materials
QAP : 053 Preparation & Submission of Technical Dossier for Regulated Markets
QAP : 018 QAP : 025 QAP : 040 QAP : 041
QAP : 032 QAP : 033
Materials Control
QAP : 012
Creation and Completion of BMR & BPR Manufacturing of Bulk Product Packing of Bulk Product Receipt, Storage and Handling of Finished
Quality Control
QAO : 016 QAP : 019 QAP : 042 QAP : 027 QAP : 039 QAP : 028 QAP : 029 QAP : 030 QAP : 020 Handling of Deviations Control of Non-Conforming Products Incident Reporting and Investigation Handling of Out of Specification (OOS) Test Results Product Recovery Handling of Market Complaints Handling of Adverse Drug Reaction Complaints Product Recall Handling of Returned Products
Quality Control of Raw & Packing Material Quality Control of Bulk & Finished Products
Self Inspection
QAP : 024
QAP : 045 Handling of Stability Samples for Domestic Market & Reporting Results of Analysis QAP : 052 Handling of Laboratory Materials Testing of Samples & Reporting of Results of QAP : 022 Analysis
Handling of Discrepancies
CAPA
QAP : 0043
15
16
18
Basic observations during the facility tour are aimed at finding out: Whether the products are being manufactured in a Qualified Facility (Qualified Building, Qualified Production Equipment, Qualified Utilities) using Validated Processes to ensure that products of required quality are manufactured consistently. 21
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? Are all components, raw materials, etc. properly identified? Status Labelling of the Stored Materials Area in Use, Equipment In Use, Materials in Process , Bulk Product , Packed Product is correct?
26
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? Do the instruments and equipment look clean and labelled and stored properly? Calibration Status of Measuring Devices is indicated on the equipment Daily check on Weighing Balances is performed
28
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? Standard calibrated weights traceable to national standards are used Is there a preventive maintenance program for: All processing and packing equipment All utilities
29
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? All Activities are carried out in accordance with the authorized written instructions Batch records used are verified and approved by QA to confirm that they are based on the current approved versions of the Master Formula Records
31
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? On-line recording of the activities performed is done in the Batch Manufacturing Record (BMR) and signed and dated by the operator and the supervisor Is data in the BMR adequate to demonstrate compliance with the GMP requirements.
32
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? Cursory data in the BMR and reference to many additional records/logs is not appreciated Deviations from the instructions are reported and investigated Non-standard batch sizes are not accepted
33
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? Receipt and verification of all materials and product- in-process is done and recorded All in-process controls are performed and recorded in the BMR
34
SCOPE OF THE AUDIT Areas of focus during the tour: What is looked at? In Quality Control Laboratory reliability of the data is verified: All instruments are calibrated Volumetric solutions are prepared and used correctly Current specifications and work records are used for analyzing the samples 35
36
SCOPE OF THE AUDIT Review of documents Quality System Documents dealing with the following are checked: Deviations Change control Non-Conforming Product Market Complaints Product Recall
38
44
46
47
50
51
53